Background. The optimal duration for acute cholangitis with bacteremia is unclear. We had treated all acute cholangitis cases with bacteremia at least for two weeks. However, TG13 recommended minimum duration of 2 weeks only when bacteremia with Gram-positive cocci is present. We have implemented shorter duration of antimicrobial treatment for acute cholangitis with bacteremia due to gram-negative bacilli since May 2013. The aim of this study was to validate our modified practice.
Methods. We collected the clinical information of all patients diagnosed as acute cholangitis with bacteremia from July 2012 to March 2014 using the electronic medical record at Kameda Medical Center. TG13 diagnostic criteria were used to confirm the diagnosis of acute cholangitis. The patients who had gram-positive bacteremia, biliary tract malignancies, complication of cholecystitis or hepatic abscesses, and did not receive endoscopic-retrograde cholangiopancreatography were excluded. Baseline characteristics of the patients, Pitt bacteremia score, TG13 severity index, the duration of antimicrobial treatment, 30-day mortality, and recurrence rate within 3 months were retrospectively compared before and after May 2013.
Results. A total of 224 episodes of acute cholangitis were treated during the study term and 96 fulfilled the case definitions. 42 episodes were treated before and 54 were treated after May 2013. There were no significant differences in baseline characteristics, Pitt bacteremia score and TG13 severity index. The duration of antimicrobial treatment was shorter (15.2 days vs 10.0 days; P < 0.001) in the patients treated after May 2013. 30-day mortality and recurrence rate did not significantly differ (5.1%, vs 0%; P = 0.17, 13.3% vs 3.3%; P = 0.19).
Conclusion. Our study suggests shorter duration of antimicrobial therapy seems adequate in treating acute cholangitis with bacteremia due to gram-negative bacilli once source of infection is controlled.
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